News & Analysis on Clinical Trial Services & Contract Research And Development
After making waves with its launch in June, Javara this week has signed a letter of intent to design an operating model to integrate clinical trials at a medical center in Winston-Salem, NC.
SignalPath is creating a research consortium through which it aims to leverage real world data to redesign clinical trials.
Tissue Solutions has acquired HistologiX, expanding its offering to create “one stop shop” for human tissue and related CRO services.
Brammer Bio’s three-year, $200m investment program is set to establish more than 30 suites for both clinical and commercial viral vector supply.
The European Medicines Agency has unearthed a ‘sartan’ medication, in losartan, that contains low levels of the carcinogenic substance, N-nitrosodiethylamine.
Gilead says launching generic versions of its pricey hepatitis C drugs more than a decade prior to patent expiries will more closely align product list prices with their cost.
Camrus, a Swedish pharmaceutical company, announced that its drug, Buvidal, has been recommend for approval by the CHMP.